EID Parry (India) Ltd

EID Parry (India) Ltd

₹ 546 0.12%
28 Mar 3:14 p.m.
About

EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]

Key Points

Business Segments & Revenue split FY23
Product Segment:Sugar (~70%): Manufacture, sale, and marketing of sugar in various forms. The Sugar is sold both to trade and institutions and also to consumers through retail channels.

  • Market Cap 9,695 Cr.
  • Current Price 546
  • High / Low 664 / 452
  • Stock P/E 46.1
  • Book Value 161
  • Dividend Yield 1.73 %
  • ROCE 12.3 %
  • ROE 9.93 %
  • Face Value 1.00

Pros

  • Company has been maintaining a healthy dividend payout of 51.5%

Cons

  • Stock is trading at 3.43 times its book value
  • Promoter holding has decreased over last quarter: -2.28%
  • Company has a low return on equity of 11.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Sugar Industry: Sugar

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
439 564 450 438 686 921 722 644 725 807 698 726 668
424 407 466 440 634 740 725 632 679 590 725 726 659
Operating Profit 15 158 -16 -2 52 181 -4 12 45 218 -27 -1 9
OPM % 4% 28% -4% -0% 8% 20% -0% 2% 6% 27% -4% -0% 1%
382 122 12 117 6 128 59 114 17 -45 12 132 16
Interest 20 17 11 13 11 10 8 9 8 10 12 7 7
Depreciation 31 28 28 30 30 32 33 35 33 34 35 36 37
Profit before tax 346 234 -44 72 16 267 14 81 21 128 -62 87 -20
Tax % 2% 28% 25% -1% -12% 16% 9% -5% 25% 35% 26% 1% 33%
339 169 -33 73 18 225 13 85 16 83 -46 86 -14
EPS in Rs 19.15 9.52 -1.87 4.13 1.03 12.69 0.74 4.80 0.89 4.66 -2.58 4.85 -0.77
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
1,542 1,992 1,782 2,081 2,601 2,248 1,921 1,845 1,875 2,024 2,489 2,895 2,899
1,438 1,759 1,683 1,863 2,540 1,903 1,754 1,876 1,780 1,854 2,280 2,626 2,701
Operating Profit 104 233 99 218 61 345 167 -31 94 171 209 268 199
OPM % 7% 12% 6% 10% 2% 15% 9% -2% 5% 8% 8% 9% 7%
170 373 163 171 97 157 126 372 141 1,101 269 147 114
Interest 64 137 196 151 167 140 113 113 136 93 46 36 37
Depreciation 74 108 97 102 112 111 113 114 120 120 120 135 142
Profit before tax 136 361 -31 136 -122 252 67 114 -20 1,058 312 245 133
Tax % -1% 8% 185% -9% 24% -13% -50% -43% 109% 18% 9% 20%
137 332 27 148 -92 284 101 163 2 865 284 197 110
EPS in Rs 7.91 18.87 1.51 8.43 -5.24 16.13 5.71 9.22 0.10 48.83 15.98 11.09 6.16
Dividend Payout % 51% 32% 0% 36% 0% 25% 53% 33% 0% 0% 69% 86%
Compounded Sales Growth
10 Years: 4%
5 Years: 9%
3 Years: 16%
TTM: -4%
Compounded Profit Growth
10 Years: 12%
5 Years: 9%
3 Years: 440%
TTM: -29%
Stock Price CAGR
10 Years: 15%
5 Years: 22%
3 Years: 19%
1 Year: 17%
Return on Equity
10 Years: 8%
5 Years: 9%
3 Years: 11%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 17 18 18 18 18 18 18 18 18 18 18 18 18
Reserves 1,200 1,329 1,262 1,352 1,265 1,460 1,620 1,696 1,696 2,576 2,742 2,864 2,836
885 1,834 1,977 1,845 1,319 943 1,018 832 1,090 603 147 547 309
342 454 573 681 1,128 1,019 1,386 1,339 1,266 1,077 1,168 557 548
Total Liabilities 2,444 3,635 3,829 3,895 3,730 3,440 4,042 3,885 4,069 4,275 4,075 3,986 3,711
765 1,230 1,481 1,481 1,508 1,480 1,391 1,287 1,329 1,118 1,244 1,258 1,320
CWIP 49 62 49 24 33 8 5 11 19 112 15 98 130
Investments 683 871 545 683 811 786 878 979 999 1,010 1,119 992 993
947 1,472 1,754 1,708 1,378 1,166 1,768 1,607 1,722 2,034 1,698 1,639 1,268
Total Assets 2,444 3,635 3,829 3,895 3,730 3,440 4,042 3,885 4,069 4,275 4,075 3,986 3,711

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-7 -93 146 293 945 518 -19 -4 -16 -37 439 -367
-83 -188 143 -1 -95 27 45 397 -32 645 269 76
111 261 -262 -323 -808 -594 -26 -393 57 -605 -690 269
Net Cash Flow 21 -20 27 -31 42 -48 -1 0 10 3 18 -21

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 52 39 51 46 36 34 26 32 32 36 21 26
Inventory Days 90 228 319 285 147 187 316 258 274 252 207 185
Days Payable 44 71 116 131 173 72 163 108 125 80 72 53
Cash Conversion Cycle 98 197 253 201 9 150 178 182 180 208 157 158
Working Capital Days 87 157 148 109 -47 -20 -21 0 30 116 44 117
ROCE % 10% 9% 4% 9% 2% 15% 10% 7% 4% 14% 12% 12%

Shareholding Pattern

Numbers in percentages

1 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
44.74% 44.74% 44.68% 44.66% 44.64% 44.61% 44.56% 44.55% 44.55% 44.52% 44.52% 42.24%
8.90% 8.28% 7.81% 8.21% 8.76% 10.21% 11.51% 11.65% 11.27% 10.40% 9.03% 8.71%
2.37% 3.89% 4.40% 4.10% 4.26% 4.45% 4.46% 4.44% 4.92% 4.76% 4.52% 4.92%
43.98% 43.09% 43.11% 43.04% 42.34% 40.73% 39.46% 39.36% 39.26% 40.32% 41.94% 44.12%
No. of Shareholders 58,10168,36972,53169,72975,30376,12178,19482,50379,93788,1421,07,6401,08,246

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls